Cargando…
20 Safer Delivery of Aerosolized Medications When Dealing With COVID-19 and Other Contagious Airborne Viruses
Autores principales: | Pepe, P.E., Rios, S., Leal, L., Cardona, J.C., McNally, M.A., Roach, J.P., Antevy, P.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335408/ http://dx.doi.org/10.1016/j.annemergmed.2021.07.021 |
Ejemplares similares
-
Are aerosol-generating procedures safer in an airborne infection isolation room or operating room?
por: Tsui, Ban C.H., et al.
Publicado: (2020) -
60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination
por: Pepe, P.E., et al.
Publicado: (2021) -
23 Degree, Timing and Factors Observed in COVID-19 Post-Vaccination Humoral Antibody Development
por: Pepe, P.E., et al.
Publicado: (2021) -
The airborne contagiousness of respiratory viruses: A comparative analysis and implications for mitigation
por: Mikszewski, Alex, et al.
Publicado: (2022) -
A Dental Response to the COVID-19 Pandemic—Safer Aerosol-Free Emergent (SAFER) Dentistry
por: Benzian, Habib, et al.
Publicado: (2020)